The Improvement of Lactic Acid Bacteria on Depression: A Review

被引：0
|
作者：
Guo L. [1 ]
Wang L. [2 ]
机构：
[1] College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin
[2] Food Processing Institute, Heilongjiang Academy of Agricultural Sciences, Harbin
来源：
Journal of Chinese Institute of Food Science and Technology | 2020年 / 20卷 / 07期
关键词：
Depression; Gut microbiota; Lactic acid bacteria; Microbiota-gut-brain axis; Psychobiotics;
D O I：
10.16429/j.1009-7848.2020.07.038
中图分类号：
O62 [有机化学]; TQ [化学工业];
学科分类号：
070303 ; 0817 ; 081704 ;
摘要：
Depression is one of the leading causes of disease burden worldwide, and is an important public-health problem. Occurrence and development of depression is closely associated with the gut microbiota. In recent years, particular attention has been paid to lactic acid bacteria for their potential to improve neuropsychiatric disorders such as depression. A psychobiotic was defined as a live organism that, when ingested in adequate amounts, produces a health benefit in patients suffering from psychiatric illness. Strains of lactic acid bacteria with anti-depression activity belong to the genera Lactobacillus, Bifidobacterium and Enterococcus. The purpose of this paper is to provide a comprehensive overview on the relationship between intestinal microbiota and depression, the genus and species of anti-depressant lactic acid bacteria, and the improvement and mechanism of lactic acid bacteria on depression, aiming to provide a useful guidance for the anti-depressant of lactic acid bacteria and the development of products containing lactic acid bacteria. © 2020, Editorial Office of Journal of CIFST. All right reserved.
引用
收藏
页码：317 / 325
页数：8
相关论文
共 70 条
  • [41] BJORKHOLM C., MONTEGGIA L M., BDNF-a key transducer of antidepressant effects, Neuropharmacology, 102, pp. 72-79, (2016)
  • [42] ABILDGAARD A, ELFVING B, HOKLAND M, Et al., Probiotic treatment protects against the pro-depressant-like effect of high-fat diet in Flinders Sensitive Line rats, Brain Behavior and Immunity, 65, pp. 33-42, (2017)
  • [43] STEENBERGEN L, SELLARO R, VAN HEMERT S, Et al., A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood, Brain Behavior and Immunity, 48, pp. 258-264, (2015)
  • [44] ROMIJN A R, RUCKLIDGE J J, KUIJER R G, Et al., A double-blind, randomized, placebo-controlled trial of Lactobacillus helveticus and Bifidobacterium longum for the symptoms of depression, Australian and New Zealand Journal of Psychiatry, 51, 8, pp. 810-821, (2017)
  • [45] CANLI T., Reconceptualizing major depressive disorder as an infectious disease, Biology of Mood & Anxiety Disorders, 4, (2014)
  • [46] NEUFELD K A, KANG N, BIENENSTOCK J, Et al., Effects of intestinal microbiota on anxiety-like behavior, Communicative & Integrative Biology, 4, 4, pp. 492-494, (2011)
  • [47] WOO J, AHN J., Probiotic-mediated competition, exclusion and displacement in biofilm formation by food-borne pathogens, Letters in Applied Microbiology, 56, 4, pp. 307-313, (2013)
  • [48] DENG K, CHEN T T, WU Q L, Et al., In vitro and in vivo examination of anticolonization of pathogens by Lactobacillus paracasei FJ861111.1, Journal of Dairy Science, 98, 10, pp. 6759-6766, (2015)
  • [49] JENA P K, TRIVEDI D, CHAUDHARY H, Et al., Bacteriocin PJ4 active against enteric pathogen produced by Lactobacillus helveticus PJ4 isolated from gut microflora of Wistar Rat (Rattus norvegicus): Partial purification and characterization of bacteriocin, Applied Biochemistry and Biotechnology, 169, 7, pp. 2088-2100, (2013)
  • [50] BRON P A, KLEEREBEZEM M, BRUMMER R J, Et al., Can probiotics modulate human disease by impacting ntestinal barrier function?, British Journal of Nutrition, 117, 1, pp. 93-107, (2017)
1234567